Mark Sculpher

Ontology type: schema:Person     

Person Info





Publications in SciGraph latest 50 shown

  • 2018-12 Decision uncertainty and value of further research: a case-study in fenestrated endovascular aneurysm repair for complex abdominal aortic aneurysms in COST EFFECTIVENESS AND RESOURCE ALLOCATION
  • 2017-03 Analyzing Health-Related Quality of Life Data to Estimate Parameters for Cost-Effectiveness Models: An Example Using Longitudinal EQ-5D Data from the SHIFT Randomized Controlled Trial in ADVANCES IN THERAPY
  • 2016-12 Rationale and design of the Clinical Evaluation of MAgnetic Resonance imaging in Coronary heart disease 2 trial (CE-MARC 2): A prospective, multi-centre, randomized controlled trial of diagnostic strategies for suspected coronary heart disease in JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE
  • 2016-12 Methods for network meta-analysis of continuous outcomes using individual patient data: a case study in acupuncture for chronic pain in BMC MEDICAL RESEARCH METHODOLOGY
  • 2016-08 Cost Effectiveness of Protease Inhibitor Monotherapy Versus Standard Triple Therapy in the Long-Term Management of HIV Patients: Analysis Using Evidence from the PIVOT Trial in PHARMACOECONOMICS
  • 2016-04 Should the Lambda (λ) Remain Silent? in PHARMACOECONOMICS
  • 2015-12 Cost-effectiveness of fondaparinux versus enoxaparin in non-ST-elevation acute coronary syndrome in Canada (OASIS-5) in BMC CARDIOVASCULAR DISORDERS
  • 2015-06 Modelling the cost-effectiveness of public awareness campaigns for the early detection of non-small-cell lung cancer in BRITISH JOURNAL OF CANCER
  • 2014-10 What is the Quality of Economic Evaluations of Non-Drug Therapies? A Systematic Review and Critical Appraisal of Economic Evaluations of Radiotherapy for Cancer in APPLIED HEALTH ECONOMICS AND HEALTH POLICY
  • 2014-07 Using cost-effectiveness analysis to support decision making in resource poor settings: methods and practical challenges in BMC HEALTH SERVICES RESEARCH
  • 2013-12 Golimumab per il trattamento dell’artrite psoriasica in PHARMACOECONOMICS ITALIAN RESEARCH ARTICLES
  • 2013-02 Acknowledging Patient Heterogeneity in Economic Evaluation in PHARMACOECONOMICS
  • 2013-01 Cost-effectiveness of magnetic resonance imaging in coronary heart disease: an economic evaluation using data from the CE-MARC study in JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE
  • 2012-04 Golimumab for the Treatment of Psoriatic Arthritis in PHARMACOECONOMICS
  • 2012-02 Real Economics Needs to Reflect Real Decisions in PHARMACOECONOMICS
  • 2011-12 Assessment of myocardial perfusion-CMR in left main stem disease (LMS) in the CEMARC study in JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE
  • 2011-12 Using economic modelling to contribute to the prioritisation and design and clinical trials: ready for prime time in TRIALS
  • 2011-03 Valutazione di tecnologia singola presso l’Istituto Nazionale per l’Eccellenza Sanitaria e Clinica del Regno Unito in PHARMACOECONOMICS ITALIAN RESEARCH ARTICLES
  • 2011-03 Alitretinoina nell’eczema cronico grave alle mani. Valutazione di tecnologia singola presso il NICE in PHARMACOECONOMICS ITALIAN RESEARCH ARTICLES
  • 2010-12 The Analysis of Multinational Cost-Effectiveness Data for Reimbursement Decisions in PHARMACOECONOMICS
  • 2010-05 Single Technology Appraisal at the UK National Institute for Health and Clinical Excellence in PHARMACOECONOMICS
  • 2010-05 Alitretinoin for Severe Chronic Hand Eczema in PHARMACOECONOMICS
  • 2010-02 An economic model for the prevention of MRSA infections after surgery: non-glycopeptide or glycopeptide antibiotic prophylaxis? in THE EUROPEAN JOURNAL OF HEALTH ECONOMICS
  • 2009-12 Clinical e valuation of magnetic resonance imaging in coronary heart disease: The CE-MARC study in TRIALS
  • 2008-09 Subgroups and Heterogeneity in Cost-Effectiveness Analysis in PHARMACOECONOMICS
  • 2008-09 NICE’s 2008 Methods Guide in PHARMACOECONOMICS
  • 2008-01 Linee guida di buona pratica per creare modelli analitico-decisionali nella valutazione delle tecnologie sanitarie in GIORNALE ITALIANO DI HEALTH TECHNOLOGY ASSESSMENT
  • 2007-10 A Comparison of the Cost Effectiveness of Pharmacotherapy or Surgery (Laparoscopic Fundoplication) in the Treatment of GORD in PHARMACOECONOMICS
  • 2007-03 Recombinant Erythropoietin for Chemotherapy-Related Anaemia in PHARMACOECONOMICS
  • 2006-12 Assessing Generalisability in Model-Based Economic Evaluation Studies in PHARMACOECONOMICS
  • 2006-11 Better Analysis for Better Decisions in PHARMACOECONOMICS
  • 2006-11 Using Value of Information Analysis to Prioritise Health Research in PHARMACOECONOMICS
  • 2006-11 Analysis Sans Frontières in PHARMACOECONOMICS
  • 2006-05 Cost Effectiveness of Increasing the Dose Intensity of Chemotherapy with Granulocyte Colony-Stimulating Factor in Small-Cell Lung Cancer in PHARMACOECONOMICS
  • 2006-04 Good Practice Guidelines for Decision-Analytic Modelling in Health Technology Assessment in PHARMACOECONOMICS
  • 2006-02 Better Analysis for Better Decisions: Has Pharmacoeconomics Come of Age? in PHARMACOECONOMICS
  • 2006-01 Bayesian methods for evidence synthesis in cost-effectiveness analysis in PHARMACOECONOMICS
  • 2005-12 Estimating utility data from clinical indicators for patients with stable angina in THE EUROPEAN JOURNAL OF HEALTH ECONOMICS
  • 2005-12 Should patients have a greater role in valuing health states? in APPLIED HEALTH ECONOMICS AND HEALTH POLICY
  • 2005-08 The authors’ reply in PHARMACOECONOMICS
  • 2005-06 Incorporation of uncertainty in health economic modelling studies in PHARMACOECONOMICS
  • 2005-03 Using value of information analysis to inform publicly funded research priorities in APPLIED HEALTH ECONOMICS AND HEALTH POLICY
  • 2004-06 The use of probabilistic decision models in technology assessment in APPLIED HEALTH ECONOMICS AND HEALTH POLICY
  • 2002-05 Pre-operative optimisation employing dopexamine or adrenaline for patients undergoing major elective surgery: a cost-effectiveness analysis in INTENSIVE CARE MEDICINE
  • 2002-02 Cost-Effectiveness Analysis of Stratified Versus Stepped Care Strategies for Acute Treatment of Migraine in PHARMACOECONOMICS
  • 2001-12 Using Economic Evaluations to Reduce the Burden of Asthma and Chronic Obstructive Pulmonary Disease in PHARMACOECONOMICS
  • 2000-07 Economic Issues in the Prevention of Vertical Transmission of HIV in PHARMACOECONOMICS
  • 2000-05 Assessing Quality in Decision Analytic Cost-Effectiveness Models in PHARMACOECONOMICS
  • 2000-04 Costs Incurred by Patients Undergoing Advanced Colorectal Cancer Therapy in PHARMACOECONOMICS
  • 1999-07 Benefit Valuation in Economic Evaluation of Cancer Therapies in PHARMACOECONOMICS
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

        "@context": "", 
        "affiliation": [
            "affiliation": {
              "id": "", 
              "type": "Organization"
            "isCurrent": true, 
            "type": "OrganizationRole"
            "id": "", 
            "type": "Organization"
            "id": "", 
            "type": "Organization"
            "id": "", 
            "type": "Organization"
            "id": "", 
            "type": "Organization"
            "id": "", 
            "type": "Organization"
            "id": "", 
            "type": "Organization"
            "id": "", 
            "type": "Organization"
            "id": "", 
            "type": "Organization"
        "familyName": "Sculpher", 
        "givenName": "Mark", 
        "id": "sg:person.0732472471.19", 
        "sameAs": [
        "sdDataset": "persons", 
        "sdDatePublished": "2019-03-07T15:18", 
        "sdLicense": "", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        "sdSource": "s3://com-uberresearch-data-dimensions-researchers-20181010/20181011/dim_researchers/base/researchers_973.json", 
        "type": "Person"

    Download the RDF metadata as:  json-ld nt turtle xml License info


    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' ''

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' ''

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' ''

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' ''


    This table displays all metadata directly associated to this object as RDF triples.

    32 TRIPLES      10 PREDICATES      19 URIs      7 LITERALS      2 BLANK NODES

    Subject Predicate Object
    1 sg:person.0732472471.19 schema:affiliation Nc7bca34d0e88422db03b16dc1610b7ec
    10 schema:familyName Sculpher
    11 schema:givenName Mark
    12 schema:sameAs
    13 schema:sdDatePublished 2019-03-07T15:18
    14 schema:sdLicense
    15 schema:sdPublisher Ne1dab878098e45e594b95a76004d4871
    16 sgo:license sg:explorer/license/
    17 sgo:sdDataset persons
    18 rdf:type schema:Person
    19 Nc7bca34d0e88422db03b16dc1610b7ec schema:affiliation
    20 sgo:isCurrent true
    21 rdf:type schema:OrganizationRole
    22 Ne1dab878098e45e594b95a76004d4871 schema:name Springer Nature - SN SciGraph project
    23 rdf:type schema:Organization
    24 schema:Organization
    25 schema:Organization
    26 schema:Organization
    27 schema:Organization
    28 schema:Organization
    29 schema:Organization
    30 schema:Organization
    31 schema:Organization
    32 schema:Organization

    Preview window. Press ESC to close (or click here)